Readministration of Pembrolizumab after Treatment of Tuberculosis Activated by Initial Pembrolizumab Therapy

Por Murakami, Shuji, Usui, Ryou, Nakahara, Yoshiro, Kondo, Tetsuro, Kato, Terufumi, Saito, Haruhiro
Publicado no Intern Med (2020)

Diagnosis of Tuberculous Meningitis Due to Detection of ESAT-6-Specific Gamma Interferon Production in Cerebrospinal Fluid Enzyme-Linked Immunospot Assay

Por Murakami, Shuji, Takeno, Mitsuhiro, Oka, Hideaki, Ueda, Atsuhisa, Kurokawa, Takashi, Kuroiwa, Yoshiyuki, Ishigatsubo, Yoshiaki
Publicado em 2008

Clinical usefulness of testing for UDP glucuronosyltransferase 1 family, polypeptide A1 polymorphism prior to the inititation of irinotecan-based chemotherapy

Por HARADA, TAISHI, SAITO, HARUHIRO, KARINO, FUMI, ISAKA, TETSUYA, MURAKAMI, SHUJI, KONDO, TETSURO, OSHITA, FUMIHIRO, MIYAGI, YOHEI, YAMADA, KOUZO
Publicado em 2014

Tumor invasion in the central airway is a risk factor for early‐onset checkpoint inhibitor pneumonitis in patients with non‐small cell lung cancer

Por Moda, Mitsuhiro, Saito, Haruhiro, Kato, Terufumi, Usui, Ryo, Kondo, Tetsuro, Nakahara, Yoshiro, Murakami, Shuji, Yamamoto, Kouji, Yamada, Kouzo
Publicado no Thorac Cancer (2020)

Suitability of Bronchoscopic Biopsy Tissue Samples for Next-Generation Sequencing

Por Murakami, Shuji, Yokose, Tomoyuki, Nemoto, Daiji, Suzuki, Masaki, Usui, Ryou, Nakahara, Yoshiro, Kondo, Tetsuro, Kato, Terufumi, Saito, Haruhiro
Publicado no Diagnostics (Basel) (2021)

Efficacy of subsequent docetaxel +/− ramucirumab and S‐1 after nivolumab for patients with advanced non‐small cell lung cancer

Por Tamura, Nobumasa, Horinouchi, Hidehito, Sekine, Katsutoshi, Matsumoto, Yuji, Murakami, Shuji, Goto, Yasushi, Kanda, Shintaro, Fujiwara, Yutaka, Yamamoto, Noboru, Ohe, Yuichiro
Publicado no Thorac Cancer (2019)

Analysis of targeted somatic mutations in pleomorphic carcinoma of the lung using next‐generation sequencing technique

Por Manabe, Saki, Kasajima, Rika, Murakami, Shuji, Miyagi, Yohei, Yokose, Tomoyuki, Kondo, Tetsuro, Saito, Haruhiro, Ito, Hiroyuki, Kaneko, Takeshi, Yamada, Kouzo
Publicado no Thorac Cancer (2020)

Association between serum level soluble programmed cell death ligand 1 and prognosis in patients with non‐small cell lung cancer treated with anti‐PD‐1 antibody

Por Murakami, Shuji, Shibaki, Ryota, Matsumoto, Yuji, Yoshida, Tatsuya, Goto, Yasushi, Kanda, Shintaro, Horinouchi, Hidehito, Fujiwara, Yutaka, Yamamoto, Noboru, Ohe, Yuichiro
Publicado no Thorac Cancer (2020)

Association of reduced heme oxygenase-1 with excessive Toll-like receptor 4 expression in peripheral blood mononuclear cells in Behçet's disease

Por Kirino, Yohei, Takeno, Mitsuhiro, Watanabe, Reikou, Murakami, Shuji, Kobayashi, Masayoshi, Ideguchi, Haruko, Ihata, Atsushi, Ohno, Shigeru, Ueda, Atsuhisa, Mizuki, Nobuhisa, Ishigatsubo, Yoshiaki
Publicado em 2008

Malignant pleural effusion as a predictor of the efficacy of anti‐PD‐1 antibody in patients with non‐small cell lung cancer

Por Shibaki, Ryota, Murakami, Shuji, Shinno, Yuki, Matsumoto, Yuji, Goto, Yasushi, Kanda, Shintaro, Horinouchi, Hidehito, Fujiwara, Yutaka, Motoi, Noriko, Yamamoto, Noboru, Ohe, Yuichiro
Publicado no Thorac Cancer (2019)

Mixed response to osimertinib and the beneficial effects of additional local therapy

Por Shinno, Yuki, Goto, Yasushi, Sato, Jun, Morita, Ryo, Matsumoto, Yuji, Murakami, Shuji, Kanda, Shintaro, Horinouchi, Hidehito, Fujiwara, Yutaka, Yamamoto, Noboru, Ohe, Yuichiro
Publicado no Thorac Cancer (2019)

Number of metastatic organs negatively affects the treatment sequence in patients with EGFR‐TKI failure

Por Mizuno, Takaaki, Horinouchi, Hidehito, Watanabe, Sho, Sato, Jun, Morita, Ryo, Murakami, Shuji, Goto, Yasushi, Kanda, Shintaro, Fujiwara, Yutaka, Yamamoto, Noboru, Ohe, Yuichiro
Publicado no Thorac Cancer (2020)

Evaluation of time to failure of strategy as an alternative surrogate endpoint in patients with lung cancer with EGFR mutations

Por Shinno, Yuki, Goto, Yasushi, Watanabe, Sho, Sato, Jun, Morita, Ryo, Matsumoto, Yuji, Murakami, Shuji, Kanda, Shintaro, Horinouchi, Hidehito, Fujiwara, Yutaka, Yamamoto, Noboru, Ohe, Yuichiro
Publicado no ESMO Open (2018)

Efficacy and safety of crizotinib in patients with ROS1 rearranged non-small cell lung cancer: a retrospective analysis

Por Masuda, Ken, Fujiwara, Yutaka, Shinno, Yuki, Mizuno, Takaaki, Sato, Jun, Morita, Ryo, Matsumoto, Yuji, Murakami, Shuji, Goto, Yasushi, Kanda, Shintaro, Horinouchi, Hidehito, Yamamoto, Noboru, Ohe, Yuichiro
Publicado no J Thorac Dis (2019)

Tissue surface area and tumor cell count affect the success rate of the Oncomine Dx Target Test in the analysis of biopsy tissue samples

Por Nemoto, Daiji, Yokose, Tomoyuki, Katayama, Kayoko, Murakami, Shuji, Kato, Terufumi, Saito, Haruhiro, Suzuki, Masaki, Eriguchi, Daisuke, Samejima, Joji, Nagashima, Takuya, Ito, Hiroyuki, Yamada, Kouzo, Nakayama, Haruhiko, Masuda, Munetaka
Publicado no Thorac Cancer (2020)

Clinicopathological features and EGFR gene mutation status in elderly patients with resected non–small-cell lung cancer

Por Nishii, Teppei, Yokose, Tomoyuki, Miyagi, Yohei, Daigo, Yataro, Ito, Hiroyuki, Isaka, Tetsuya, Imai, Kentaro, Murakami, Shuji, Kondo, Tetsuro, Saito, Haruhiro, Oshita, Fumihiro, Yamada, Kouzo, Matsukuma, Shoichi, Tsuboi, Masahiro, Nakayama, Haruhiko, Masuda, Munetaka
Publicado em 2014

Three-Year Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC—Update from PACIFIC

Por Gray, Jhanelle E., Villegas, Augusto, Daniel, Davey, Vicente, David, Murakami, Shuji, Hui, Rina, Kurata, Takayasu, Chiappori, Alberto, Lee, Ki Hyeong, Cho, Byoung Chul, Planchard, David, Paz-Ares, Luis, Faivre-Finn, Corinne, Vansteenkiste, Johan F., Spigel, David R., Wadsworth, Catherine, Taboada, Maria, Dennis, Phillip A., Özgüroğlu, Mustafa, Antonia, Scott J.
Publicado no J Thorac Oncol (2019)